Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives
✍ Scribed by Dr Lindsay A. Farrer; L. Adrienne Cupples; Cornelia M. Van Duijn; Alexander Kurz; Reinhilde Zimmer; Ulrich Müller; Robert C. Green; Valerie Clarke; John Shoffner; Douglas C. Wallace; Helena Chui; Steven D. Flanagan; Ranjan Duara; Peter St. George-Hyslop; Sanford A. Auerbach; Ladislav Volicer; John M. Wells; Christine Van Broeckhoven; John H. Growdon; Jonathan L. Haines
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 967 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We examined 180 siblings of 127 probands with probable or possible Alzheimer's dementia (AD) in a family study of AD. The overall sensitivity of a simple family history questionnaire was 64% and the specificity was 84%. Sensitivity improved 90-100% with minimal decline in specificity when we conside
## Abstract ## Objective Virtually all adults with Down syndrome (DS) have neuropathological manifestations of Dementia in Alzheimer's disease (DAD) but not all develop clinical psychopathology. The effect of allelic variants of Apolipoprotein (APOE) gene in development and progression of DAD and